China Care helps international patients organise the practical path to hospital review for commercial CAR-T options in China. The treating hospital and specialist decide whether they can review a case, clinical suitability, product options, timing, and medical costs.
CAR-T is a specialised treatment pathway. A hospital needs to consider the specific diagnosis, treatment history, current clinical situation, and its own available options before it can make any medical decision.
Tell China Care your diagnosis, current country, previous treatment history, and what you hope to understand. You do not need to send every record in your first message.
If you choose formal Case Coordination, China Care can explain which available records a hospital may request and what practical questions need answering first.
A treating specialist decides whether a review, further assessment, or a commercial CAR-T pathway may be relevant. China Care does not make this determination.
Important: Nothing on this page confirms that a particular product, hospital, trial, or treatment option is available or appropriate for an individual patient. Only the treating hospital can do that after its own review.
China Care can coordinate agreed outreach, but an institution may need additional documents or may decide that another route is more appropriate.
The relevant records, tests, translations, and consultation route depend on the hospital and the individual case.
Assessment, admission, manufacturing, monitoring, and travel requirements vary by the hospital, product pathway, and the patient’s current situation.
A product list price is not the same as a complete treatment cost. The treating hospital confirms its own medical estimate after review.
The first conversation is free. Any formal coordination begins only after the scope, fee, timing, and separate institutional costs are confirmed in writing.
Explain what you are trying to understand. China Care can clarify the practical service options, but does not diagnose, recommend treatment, or confirm eligibility.
Case Coordination is for a complex case when you need help deciding which hospitals or facilities are worth approaching first. It includes record organisation, matching and outreach to up to two agreed institutions, and a practical next-step summary within the agreed scope. See the service definition and fee.
The hospital decides whether it can review or accept the case, what information it needs, and whether a commercial CAR-T pathway may be relevant. This is the hospital’s clinical decision.
Before formal treatment-stage coordination, China Care helps you understand the hospital’s practical next step, the confirmed coordination scope, and the separate hospital and third-party costs that may apply.
CAR-T cell therapy is a form of immunotherapy in which a patient’s own T cells are modified to recognise certain cancer cells. It is used in specific settings and requires specialist assessment, manufacturing, treatment, and monitoring under the treating hospital’s care.
China has NMPA-approved commercial CAR-T products. The current approved indications, product availability, and whether any product is relevant to a patient must be confirmed with the treating hospital and current official product information.
A CAR-T product list price is not the same as the complete medical cost. Hospitals confirm consultation, testing, treatment, admission, and other medical charges directly for an individual case.
China Care services have defined fees and a written scope. For a confirmed commercial CAR-T or BMT pathway, Full Service is described on the Pricing page.
The treating hospital confirms and collects its own consultation, test, product, admission, treatment, and monitoring costs directly.
Flights, accommodation, insurance, transport, and separately arranged support are confirmed separately before any arrangement is made.
The directory helps international patients research hospitals by city and specialty. A directory listing is not a promise that a hospital can review a case, provide a particular product, or accept an international patient.
Explore Hospital DirectoryStart with the practical questions that can be answered before travel. Medical suitability remains a hospital decision.
This page focuses on commercially available CAR-T pathways. Clinical-trial enrolment is not a standard route for international patients and is determined solely by the research team and trial protocol. China Care does not present a trial as a guaranteed or default alternative.
The treating hospital and specialist decide whether they can review or accept a case, clinical suitability, product relevance, treatment plan, admission timing, and medical charges. China Care coordinates agreed access and communication.
Start with a short description of the diagnosis, current country, previous treatment history, and what you hope to understand. You do not need to send every medical record, passport scan, payment detail, or imaging file in your first message.
Your first conversation is free. If you choose a formal service, China Care confirms the written scope and fee before coordination begins. Hospitals confirm and collect their own medical charges directly. See service fees and payment boundaries.
Timelines vary by the hospital, product pathway, availability, assessment requirements, manufacturing, monitoring, and the patient’s clinical situation. Do not make travel plans until the treating hospital has explained the practical next step for the individual case.
No. China Care does not arrange visa applications or issue invitation letters. Visa requirements and entry decisions are determined by the relevant authorities and should be confirmed with the appropriate embassy, visa centre, or immigration authority.
The hospital or facility decides whether it can review or accept a case. Once agreed coordination has begun, China Care service fees are non-refundable because the agreed record organisation, communication, and outreach work has already been completed within scope. China Care explains the response and practical next step available.
You can start with a short summary. China Care will explain the practical next step and, if formal coordination may help, what needs to be confirmed before work begins.